Press Release
Global Lipid Market Set to Surpass USD 21.20 Billion by 2031, Driven by Pharma Innovation and Functional Nutrition Demand
Bonafide Research has released its latest findings on the global lipid market, revealing robust growth momentum fueled by aging demographics, pharmaceutical advancements, and evolving supply chain dynamics.
The global lipid market, valued at over USD 14.86 billion in 2025, is projected to reach USD 21.20 billion by 2031, expanding at a CAGR of 6.27%. Lipids  including omega-3 and omega-6 fatty acids, phospholipids, medium-chain triglycerides (MCTs), sterols, and sphingolipids  are essential ingredients across food, nutraceuticals, pharmaceuticals, personal care, and biotechnology sectors.
Industry Shift: From Commodity to Precision Formulation
A defining transformation in the lipid industry is the strategic pivot of leading life-science companies away from commodity operations toward high-value formulation partnerships. Major players such as Evonik, Croda, BASF, Gattefossé, and CordenPharma are now offering GMP-compliant, nano-encapsulated lipid delivery platforms tailored for pharmaceutical and clinical cosmetic developers. The industry’s future is increasingly defined by precision rather than volume.
Simultaneously, large-scale agricultural processors like Wilmar, ADM, and Bunge continue managing feedstock volatility arising from biofuel blending mandates, including Brazil’s B15 policy.
Supply Chain Sustainability Under the Spotlight
Palm and soybean oils — predominantly sourced from Southeast Asia and South America — remain the primary agricultural inputs. However, enforcement of the EU Deforestation Regulation is pushing major crushers like Cargill and Bunge to adopt geo-tracked, deforestation-free sourcing to retain access to European markets.
Marine-sourced omega-3 supply faces disruption from El Niño cycles and tightening catch quotas. In response, investment is flowing toward automated microalgae fermentation — a scalable, climate-resilient alternative for producing high-purity EPA and DHA.
Asia-Pacific Leading Supply and Consumption
Asia-Pacific holds a dual role as both the world’s primary lipid feedstock supplier and a fast-growing consumer market. Indonesia and Malaysia dominate palm derivatives, while China and Japan are investing heavily in closed-loop microalgae fermentation. The regional market is expected to exceed USD 7.47 billion by 2031, with China accounting for 58% of the region’s marine lipid imports.
Aging populations across Japan and China are accelerating demand for cognitive and cardiovascular health ingredients such as krill oil and phosphatidylserine.
India’s Emerging Opportunity
India’s lipid market is forecast to surpass USD 514 million by 2031. Despite producing 40–42 million metric tons of oilseeds annually, India still imports over 55–60% of its edible oil needs. With USD 2.5–3 billion in life sciences investments recorded in 2024, India’s pharmaceutical and nutraceutical sectors are becoming significant consumers of lipid-based formulations.
Contact:
Steven Thomas — Sales & Marketing Manager
[email protected] | +91 7878231309
